XML 33 R22.htm IDEA: XBRL DOCUMENT v3.25.1

Segment Reporting (Tables)

3 Months Ended

Mar. 31, 2025

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

The table below summarizes the significant expenses regularly reviewed by the CODM (in thousands):

			Three Months Ended March 31,
			2025						2024
Total revenue (a)			$	13,192					$	9,104
Cost of product sales			—						270
Cost of manufacturing services			5,400						1,846
Research and development expenses:
Lorigerlimab			8,877						9,616
Vobramitamab duocarmazine			8,267						9,668
MGC026			5,953						3,956
MGC028			3,934						6,204
MGC030			2,506						1,636
Next-generation T-cell engagers			2,273						2,489
MGD024			2,192						2,786
Preclinical antibody-drug conjugates (ADCs)			1,799						2,962
Margetuximab			319						3,123
Other programs			3,578						3,589
Total research and development expenses			39,698						46,029
Selling, general and administrative expenses			10,718						14,709
Other segment income, net (b)			1,588						1,560
Net loss			$	(41,036)					$	(52,190)

(a) Total revenue includes collaborative and other agreements, product sales, net, contract manufacturing, and government agreements.

(b) Other segment income, net includes interest and other income and other expense.

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration